Skip to content
10-Q

Quarterly Report

BIOPLUS LIFE CORP

0001493152-19-017192

← back to feed
Filed
Nov 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 13, 2019 359.31M sh
Cash And Equivalents Q3 2019 · Sep 30, 2019 $100.73K
Cash And Equivalents Q3 2019 · Dec 31, 2018 $398.13K
Stockholders Equity Q3 2019 · Sep 30, 2019 $1.79M
Stockholders Equity Q3 2019 · Dec 31, 2017 $1.83M
Current Liabilities Q3 2019 · Sep 30, 2019 $314.22K
Current Liabilities Q3 2019 · Dec 31, 2018 $976.35K
Total Liabilities Q3 2019 · Sep 30, 2019 $1.02M
Total Liabilities Q3 2019 · Dec 31, 2018 $1.67M
Current Assets Q3 2019 · Sep 30, 2019 $691.54K
Current Assets Q3 2019 · Dec 31, 2018 $1.28M
Total Assets Q3 2019 · Sep 30, 2019 $2.81M
Total Assets Q3 2019 · Dec 31, 2018 $3.47M
Net Income Q3 2019 · Dec 31, 2018 −$110.34K
Net Income Q3 2019 · Sep 30, 2018 −$316.51K
Net Income Q3 2019 · Sep 30, 2018 $323.48K
Capex Q3 2019 · Sep 30, 2018 $199.78K
Operating Cash Flow Q3 2019 · Sep 30, 2018 $196.11K
Sga Expense Q3 2019 · Sep 30, 2018 $260.68K
Sga Expense Q3 2019 · Sep 30, 2018 $766.52K
Operating Income Q3 2019 · Sep 30, 2018 −$316.51K
Operating Income Q3 2019 · Sep 30, 2018 $323.48K
Gross Profit Q3 2019 · Sep 30, 2018 $594.42K
Gross Profit Q3 2019 · Sep 30, 2018 $1.13M
Cost Of Revenue Q3 2019 · Sep 30, 2018 $537.77K
Cost Of Revenue Q3 2019 · Sep 30, 2018 $1.28M
Revenue Q3 2019 · Sep 30, 2018 $1.13M
Revenue Q3 2019 · Sep 30, 2018 $2.41M